Cellular viral rebound after cessation of potent antiretroviral therapy predicted by levels of multiply spliced HIV-1 RNA encoding nef

J Infect Dis. 2004 Dec 1;190(11):1979-88. doi: 10.1086/425983. Epub 2004 Nov 3.

Abstract

To characterize newly arising replication of human immunodeficiency virus (HIV) type 1 in vivo at the cellular level, distinct viral RNA species in peripheral blood mononuclear cells (PBMCs) from HIV-1-infected patients were monitored during 2 weeks of structured treatment interruption (STI). HIV-1 RNA encoding tat/rev and PBMC-associated virions were almost completely depleted during antiretroviral therapy and emerged simultaneously after 2 weeks of STI, thus specifically reflecting productive viral infection at the cellular level. The magnitude of these correlates of reappearing cellular viral replication was predicted by during-therapy levels of nef transcripts in PBMCs. Significant rebound of plasma viremia, representing the progeny of a broader range of anatomical compartments, preceded and predicted productive infection in PBMCs. Thus, cellular viral rebound in PBMCs likely was primed before STI by the expression of nef in HIV-1-infected PBMCs that lacked virion production and was subsequently triggered by the plasma viremia that preceded the recurrence of productively infected PBMCs.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-HIV Agents / therapeutic use*
  • Cells, Cultured
  • Drug Therapy, Combination
  • Gene Products, nef / analysis
  • Gene Products, nef / biosynthesis*
  • Gene Products, rev / metabolism
  • Gene Products, tat / metabolism
  • HIV Infections / blood
  • HIV Infections / drug therapy*
  • HIV Infections / virology
  • HIV-1 / genetics
  • HIV-1 / isolation & purification*
  • Humans
  • Leukocytes, Mononuclear / virology*
  • Neutrophils / virology
  • RNA Splicing*
  • RNA, Viral / analysis
  • RNA, Viral / biosynthesis*
  • Recurrence
  • Virus Replication
  • nef Gene Products, Human Immunodeficiency Virus
  • rev Gene Products, Human Immunodeficiency Virus
  • tat Gene Products, Human Immunodeficiency Virus

Substances

  • Anti-HIV Agents
  • Gene Products, nef
  • Gene Products, rev
  • Gene Products, tat
  • RNA, Viral
  • nef Gene Products, Human Immunodeficiency Virus
  • rev Gene Products, Human Immunodeficiency Virus
  • tat Gene Products, Human Immunodeficiency Virus